Statement from FDA Commissioner Scott Gottlieb, M.D., and Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research on the agency’s list of known nitrosamine-free valsartan and ARB class medicines, as part of agency’s ongoing efforts to resolve ongoing safety issue - FDA Press Releases

FDA announces list of nitrosamine-free ARB medications confirmed by the agency to help patients and healthcare providers

from Food and Drug Administration--Press Releases https://ift.tt/2OLt512
via IFTTT